Extendicare (TSE:EXE - Free Report) had its target price hoisted by TD Securities from C$10.50 to C$13.00 in a research note published on Monday morning,BayStreet.CA reports. The firm currently has a hold rating on the stock.
A number of other analysts have also weighed in on EXE. Cormark raised Extendicare to a "moderate buy" rating in a research note on Wednesday, February 19th. Royal Bank of Canada boosted their price objective on shares of Extendicare from C$9.50 to C$11.00 and gave the company a "sector perform" rating in a research report on Thursday, November 28th. Finally, BMO Capital Markets raised their target price on Extendicare from C$11.00 to C$13.50 in a research note on Monday. Three investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average target price of C$11.50.
View Our Latest Stock Analysis on EXE
Extendicare Price Performance
TSE:EXE traded up C$0.08 during mid-day trading on Monday, reaching C$13.09. The stock had a trading volume of 101,821 shares, compared to its average volume of 184,593. The stock has a market capitalization of C$1.09 billion, a P/E ratio of 16.69 and a beta of 1.26. Extendicare has a one year low of C$6.83 and a one year high of C$13.12. The firm has a 50 day moving average price of C$10.89 and a two-hundred day moving average price of C$9.90. The company has a debt-to-equity ratio of 283.02, a quick ratio of 0.98 and a current ratio of 0.62.
Extendicare Announces Dividend
The company also recently disclosed a monthly dividend, which will be paid on Monday, March 17th. Shareholders of record on Monday, March 17th will be given a dividend of $0.04 per share. This represents a $0.48 annualized dividend and a yield of 3.67%. The ex-dividend date is Friday, February 28th. Extendicare's dividend payout ratio is currently 61.20%.
About Extendicare
(
Get Free Report)
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.
Read More
Before you consider Extendicare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.
While Extendicare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.